Elix Extends Agreement to use Neonode Technology in Displays for Global OEM Medical Supplier

0
206


STOCKHOLM, Oct. 20, 2022 /PRNewswire/ — Neonode Inc. (NASDAQ: NEON) is happy to announce that Elix Systems SA has prolonged its settlement with Neonode and can improve the use of Neonode’s Touch Sensor Modules to allow contact interplay on shows in medical ultrasound methods. The new settlement covers deliveries throughout 2022 and 2023 with a complete worth of over $400,000.

Swiss-based Elix Systems designs and produces electronics methods for extremely demanding industries reminiscent of avionics and medical. They have chosen Neonode’s Touch Sensor Modules for use in medical ultrasound methods to allow contact interplay on the shows. 

Elix integrates a 374 mm Neonode Touch Sensor Module right into a Touch Frame System that permits contact performance on 19″ LCD medical shows in ultrasound methods. The high-performing contact capabilities give physicians the chance to present informative session and supply a extra interactive session and extra informative prognosis to sufferers. 

Frederic Guitard, Chief Operating Officer at Elix Systems says “We selected Neonode technology because the Touch Sensor Modules could fit in the existing design of the equipment and meet the performance requirements. Alternative projected capacitive touch solutions would have meant a redesign and compliance recertification of the medical devices.”

“We are delighted and excited that our business with Elix in the medical segment continues and expands. We look forward to continuing our great ongoing cooperation with them,” says Johan Swartz, Vice President Marketing & Sales at Neonode.

For extra info, please contact:

CONTACT:

Chief Executive Officer
Urban Forssell
E-mail: [email protected] 
Phone: +46 734 20 03 59

Vice President Marketing & Sales
Johan Swartz
E-mail: [email protected]
Phone: +46 707 64 35 44

The following information can be found for obtain: 

SOURCE Neonode



Source by [author_name]

LEAVE A REPLY

Please enter your comment!
Please enter your name here